Demonstrating cAC10-vcMMAE, an anti CD30 Monomethyl

7 Pages893 Words258 Views

Added on 2020-01-06

Demonstrating cAC10-vcMMAE, an anti CD30 Monomethyl

Added on 2020-01-06

BookmarkRelated Documents

Abstract Style Paper

Demonstrating cAC10-vcMMAE, an anti CD30 Monomethyl_1

ABSTRACTThe overall research study is based on demonstrating cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugatewith potent and selective antitumor activity. The introduction of chimeric monoclonal antibodycAC1 against CD30 produces antitumour activity in Hodgkin dis-ease.

Demonstrating cAC10-vcMMAE, an anti CD30 Monomethyl_2

Table of ContentsINTRODUCTION................................................................................................................................4MATERIALS AND METHODS.....................................................................................................4RESULTS ............................................................................................................................................5DISCUSSION.......................................................................................................................................6REFERENCE.......................................................................................................................................7

Demonstrating cAC10-vcMMAE, an anti CD30 Monomethyl_3

End of preview

Want to access all the pages? Upload your documents or become a member.